CD8A and COVID-19: In a recent study, Ćorović et al. found that COVID-19-associated myocardial fibrosis was associated with immunodysregulation of CD8+ T cells, CD8+ T effector memory (TEM), and CD4+ Th2-like cells by integrating clinical imaging and immunophenotyping (Corovic et al., 2024).